Global /Japan /Healthcare /Biotechnology /2370
chevron_leftBack
MEDINET Co., Ltd. logo

MEDINET Co., Ltd.

2370
TSE: 2370 Delayed
28JPY 0%
0.1750 USD
As of 5 June 2026, MEDINET Co., Ltd. has a market cap of $48.21M USD, ranking #30859 globally and #2876 in Japan. It ranks #2787 in the Healthcare sector, and #538 in the Biotechnology industry.
Global Rank
30859
Country Rank
2876
Sector Rank
2787
Industry Rank
538
Key Stats
Market Cap
$48.21MUSD
7.71B JPY
Revenue (TTM)
$6.24MUSD
998.0M JPY
EBITDA (TTM)
-$15.67MUSD
-2.51B JPY
Net Income (TTM)
-$19.05MUSD
-3.05B JPY
EBITDA Margin
-251%
PS Ratio
7.7
PB Ratio
2.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Kanenao Kubushiro open_in_new
Employees
92
Founded
1995
Website
medinet-inc.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -6.7% -3.4% -9.7% -20% -9.7%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
2370
株式会社メディネット
ISIN: JP3920990003
Shares Out.:
279.917M1 Shares Float: 263.517M2
TV:
SA:
YF:
GF:
BA:
MS:
28 JPY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About MEDINET Co., Ltd.

MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. It operates through two segments: Cell Processing Business and Regenerative Medicine Products Business.The company’s solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy.It also manufactures regenerative medical/investigational and specified cell products. In addition, the company offers value chain solutions, such as personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management system, quality control and assurance, and technology transfer and process development solutions. The company serves medical institutions, research institutions, and biopharmaceutical companies. MEDINET Co., Ltd. was incorporated in 1995 and is headquartered in Tokyo, Japan.

Similar Companies

Industry: Biotechnology (Japan)
Name
Market Cap diff.
PE
2160
$1.02B
162.8B JPY
2K%
-
4587
$929.34M
148.73B JPY
2K%
-
$526.28M
84.22B JPY
992%
-
4894
$349.84M
55.99B JPY
626%
-
504A
$169.93M
27.19B JPY
253%
-
$113.62M
18.18B JPY
136%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
378K%
23.9
GILD
$159.92B
332K%
19.0
ARGX
$48.01B
41.39B EUR
99K%
39.9
$44.36B
68.19T KRW
92K%
35.5
CSL
$42.98B
60.27B AUD
89K%
29.3
LONN
$42.55B
33.71B CHF
88K%
37.2
chevron_leftBack